Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: A prospective randomised study

L. W. Chen, R. N. Chien*, J. J. Chang, K. M. Fang, L. C. Chang

*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: A prospective randomised study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science